Compound ID | 1819
Synonym(s): MUT485 prodrug
Class: Beta-lactamase inhibitor (diazabicyclooctane [DBO])
| Details of activity: | Inhibits class A and C β-lactamases; for use in combination with an oral Cephalosporin |
| Combined with other compounds: | Yes |
| Description: | Synthetic compound. Oral inhibitor of serine beta-lactamases |
| Institute where first reported: | Mutabilis |
| Year first mentioned: | 2019 |
| Highest development stage: | Preclinical |
| Development status: | Inactive (as of 2022) |